October 2006
	Meet Our New Additions: Senior Leadership As a "destination employer" for the industry, the GfK U.S. Healthcare Companies continue to draw top marketing research talent. While our new researchers offer our clients a variety of methodological and therapeutic expertise, they share the common background of being marketing research veterans with experience specifically focused in the pharmaceutical industry.
	Randy Budros, Ph.D. Vice President of Research GfK Market Measures Before joining GfK Market Measures, Dr. Budros served as Group Research Director, Pharmaceutical Practice at TNS. Dr. Budros has consulted extensively with leading pharmaceutical companies on various strategic marketing projects, including conjoint/trade-off analyses for product positioning, market segmentation studies, and sales forecasting models. He is especially skilled at leveraging advanced design and analytical tools to address key marketing issues. Dr. Budros can be reached at 973.599.3515 or rbudros@gfkmarketmeasures.com.
	Robert Rava Vice President of Research GfK Market Measures Robert has had a long-standing career in the pharmaceutical field having worked for Ethicon, Roche and Bristol-Myers Squibb. He has provided executive leadership for a marketing research firm’s business expansion into strategic marketing, market segmentation, customer satisfaction and business analytical functions, and also has client-side experience having held extensive marketing and marketing research positions with various medical device and pharmaceutical companies in the areas of new market assessments, product pricing, sales forecasting, choice modeling and positioning. Robert can be reached at 609.683.6308 or brava@gfkmarketmeasures.com.
	Paul Teta, Ph.D. Executive Vice President GfK V2 Dr. Teta has extensive experience serving pharmaceutical clients in both a quantitative and qualitative capacity. He is a recognized expert in quantitative research methods including choice modeling, product optimization and pricing, positioning and market segmentation. Prior to joining GfK V2, Dr. Teta was Chief Executive Officer of Genactis, Inc. and also served as Senior Vice President of Research Operations at Migliara/Kaplan. Dr. Teta can be reached at 215.283.3200 x370 or pteta@gfkv2.com.
	Doug Willson, Ph.D. Senior Vice President of Marketing Science GfK Strategic Marketing Dr. Willson specializes in advising clients on methodological issues such as sampling, conjoint design, segmentation, statistical analysis and modeling strategies. His marketing research career spans more than 14 years and most recently, he was Vice President of Methodology at National Analysts where he developed segmentations, conjoint/choice models, market forecasts and complex physician and patient level samples in many therapeutic categories. Dr. Willson can be reached at 610.667.1649 or dwillson@gfksm.com.